GeneDx Holdings (WGS) EBITDA Margin (2020 - 2026)
GeneDx Holdings (WGS) reported EBITDA Margin of 62.17% for Q1 2026, down 5476.0% year-over-year from 1.16% in Q1 2025, and down 324.18% quarter-over-quarter from 14.66% in Q4 2025.
GeneDx Holdings (WGS) EBITDA Margin (2020 - 2026) Analysis & Trends
GeneDx Holdings (WGS) has 7 years of EBITDA Margin data on file, last reported at 62.17% in Q1 2026.
- EBITDA Margin for Q1 2026 came in at 62.17%, down 5476.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 17.63% (down 613.0% YoY), and the FY2025 annual result was 4.89%, up 1209.0% from the prior year.
- EBITDA Margin eased to 62.17% in Q1 2026 per WGS's latest filing, from 14.66% in the prior quarter.
- Over five years, EBITDA Margin peaked at 10.44% in Q2 2025 and troughed at 503.28% in Q4 2022.
- A 5-year average of 87.97% and a median of 44.15% in 2023 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2022 and 2023: EBITDA Margin sank 43375 bps in 2022, then jumped 45913 bps in 2023.
- A 5-year view of EBITDA Margin shows it stood at 503.28% in 2022, then surged by 91 bps to 44.15% in 2023, then surged by 113 bps to 5.59% in 2024, then tumbled by 362 bps to 14.66% in 2025, then sank by 324 bps to 62.17% in 2026.
- Business Quant data shows WGS's EBITDA Margin at 62.17% in Q1 2026, 14.66% in Q4 2025, and 6.38% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -3.71% |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 16.93% |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 22.58% |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 31.78% |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 21.74% |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 12.38% |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | -12.21% |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 19.16% |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 19.42% |
| 10 | GeneDx Holdings | 1.52 Bn | 1.35 Bn | 68.21 Mn | -62.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -62.17% |
| Dec 31, 2025 | -14.66% |
| Sep 30, 2025 | -6.38% |
| Jun 30, 2025 | 10.44% |
| Mar 31, 2025 | -7.41% |
| Dec 31, 2024 | 5.59% |
| Sep 30, 2024 | -10.22% |
| Jun 30, 2024 | -41.13% |
| Mar 31, 2024 | -32.64% |
| Dec 31, 2023 | -44.15% |
| Sep 30, 2023 | -79.33% |
| Jun 30, 2023 | -95.92% |
| Mar 31, 2023 | -141.38% |
| Dec 31, 2022 | -503.28% |
| Sep 30, 2022 | -93.21% |
| Jun 30, 2022 | -237.06% |
| Mar 31, 2022 | -142.56% |
| Dec 31, 2021 | -69.52% |
| Sep 30, 2021 | 75.80% |
| Jun 30, 2021 | -98.18% |